RDHL News and Press, Redhill Biopharma Ltd. From 03/11/24

RedHill Announces New USPTO Patent Covering Talicia® Through 2034 PR Newswire U.S. Patent and Trademark Office (USPTO) issues new patent covering Talicia 1 as an all-in-one treatment of Helicobacter pylori (H. pylori), supporting Talicia protection until Feb...

RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs PR Newswire The U.S. government's Chemical Medical Countermeasures (Chem MCM) Program and Chemical Countermeasures Research Program (CCRP), managed respectively by ASPR/BARDA and NIH/NIAID, in...

RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publication PR Newswire The data, published in the International Journal of Molecular Sciences, demonstrate that opaganib significantly improved long-term survival in an in vivo model of...

2024-02-09 16:29:27 ET More on RedHill RedHill gains after new patent grant for Talicia for H. pylori treatment through 2042 RedHill shares rally 20% on positive data for two antiviral drugs Financial information for RedHill Read the full article on Seeking...

RedHill Biopharma Announces Closing of $8 Million Registered Direct Offering PR Newswire TEL AVIV , Israel and RALEIGH, N.C. , Jan. 26, 2024 /PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceu...

2024-01-25 10:00:05 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Investors were most bullish on H...

RedHill Biopharma Announces $8 Million Registered Direct Offering PR Newswire TEL AVIV, Israel and RALEIGH, N.C. , Jan. 25, 2024 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, t...

2024-01-25 08:41:57 ET More on RedHill RedHill shares rally 20% on positive data for two antiviral drugs RedHill secures funding for Phase 2 study of COVID-19 treatment Financial information for RedHill Read the full article on Seeking Alpha For furth...

RedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042 PR Newswire USPTO issues new patent covering Talicia [1] as a method for eradicating H. pylori regardless of patient Body Mass Index (BMI) [2] , supporting Talic...

2024-01-10 14:14:48 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotechnology company Gilead Sciences (NASDAQ: GILD ) wasn’t a “Magnificent Seven” company or a darling of the financial markets in 2023. Yet, GILD stock deserv...